Xarelto Bleeding Injury $28M Verdict Tossed. What the court giveth, the court taketh away! Such is the capriciousness of the court system. The first Xarelto Bleeding Injury plaintiff’s victory against Bayer and Johnson & Johnson (J&J) over Xarelto’s bleeding risks was short lived. In the case of Lynn Hartman, Judge…
J&J successfully blocks first Xarelto Bleeding Injury trial. A Louisiana jury found for Johnson & Johnson and Bayer AG in the first Xarelto internal bleeding product liability lawsuit to go to trial. Xarelto Bleeding Injury Trial Xarelto linked to uncontrollable brain and gastrointestinal bleeding according to over 18,000 lawsuits. The federal…
A federal judge in Louisiana has selected two lawsuits to serve as the first test trials amid more than 7,200 cases challenging the safety of Bayer AG and Johnson & Johnson subsidiary Janssen’s blockbuster blood thinner Xarelto. The first trial, slated to start in February, involves claims Xarelto caused a…
Xarelto is a new type of blood thinner approved in 2011 by the Food and Drug Administration and marketed in the U.S. by Johnson & Johnson’s subsidiary company, Janssen Pharmaceuticals. When a person is taking blood thinners they must have routine blood tests and make adjustments to their dosage. They…
Uncontrolled bleeding caused by Xarelto has resulted in hundreds of people filing lawsuits against the company for failing to warn about the dangers associated with Xarelto. According to the Judicial Panel on Multidistrict Litigation (MDL), as of June 15, 2016, there were 5,853 lawsuits consolidated for pretrial proceedings in MDL…
An independent study conducted by the Institute for Safe Medication Practices (ISMP) showed that side effects of Xarelto were linked to more serious injuries than any other drug studied by the institute. The study, which was submitted the U.S. Food and Drug Administration (FDA) last year, links more than 1,100…
Approved in 2011, Xarelto (rivaroxaban) is one of the newest blood thinners on the market and is manufactured by Bayer and marketed in the U.S. by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. So far, Xarelto brought in about $2 billion for Bayer and J&J in 2015 alone. In the first…
Xarelto is a new type of blood thinner approved in 2011 by the Food and Drug Administration and marketed in the U.S. by Johnson & Johnson’s subsidiary company, Janssen Pharmaceuticals. When a person is taking blood thinners they must have routine blood tests and make adjustments to their dosage. They…
According to recent revelations in the New York Times did two major pharmaceutical companies, to protect their blockbuster drug, Xarelto, intentionally mislead editors at one of the world’s most prestigious medical journals? Several thousand injured plaintiffs have filed personal injury and product liability claims against Johnson & Johnson and Bayer…
Oren Fells from Georgia recently filed a Xarelto uncontrollable intracranial or brain bleeding lawsuit in the U.S. District Court for the Eastern District of Louisiana. The lawsuit was filed against Bayer Healthcare, Johnson & Johnson, and its Janssen subsidiary, the manufacturers of Xarelto. Catastrophic Xarelto Brain Bleeding Allegations Fells began…